Synergistic cytotoxic effects of an extremely low-frequency electromagnetic field with doxorubicin on MCF-7 cell line.
This in vitro study tested whether a 50 Hz, 20 mT extremely low-frequency electromagnetic field (ELF-EMF) enhances the cytotoxic effects of doxorubicin (DOX) in the MCF-7 breast cancer cell line. The authors report that combining ELF-EMF with low-dose DOX reduced cell viability at lower DOX concentrations than DOX alone and was associated with increased ROS, G0-G1 cell-cycle arrest, and apoptosis. The work suggests a potential synergistic anti-tumor effect under the studied laboratory conditions, but it does not address human exposure or clinical efficacy.
Key points
- The study is an in vitro experiment in the MCF-7 breast cancer cell line.
- Exposure was ELF-EMF at 50 Hz and 20 mT, assessed alongside doxorubicin treatment.
- Cell viability was measured by MTT at 12, 24, and 48 hours.
- DOX alone showed concentration- and time-dependent cytotoxicity within 24 hours.
- The combination reportedly reduced viability to 50% at >0.25 μM DOX (24 h), versus 2 μM DOX alone for a similar reduction.
- At 0.25 μM DOX, adding ELF-EMF was reported to increase ROS and DOX-induced apoptosis.
- Flow cytometry findings were described as enhanced G0-G1 arrest and apoptotic cell death with the combined treatment.
Referenced studies & papers
Relevant papers in OpenMel
Source:
Open original
AI-generated summaries may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.
AI-generated summaries may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.
Comments
Log in to comment.
No comments yet.